For patients managing Type 2 diabetes, weight concerns, or metabolic imbalance, GLP-1 therapy at our Sherman Oaks Medspa delivers targeted, medically backed support
[] GLP-1RAs are showing remarkable effects on BW as well as clinical, biochemical, and pathological markers in fatty liver disease and NAFLD
Improvement in fibrosis was also assessed, showing a dose-dependent trend, with 34% of patients achieving at least a 1-stage improvement in fibrosis without MASH progression in the 6 mg group (vs
Some hard truths: GLP-1s are not making our society more body-positive or body-accepting
This information is for educational purposes only and is not a substitute for medical advice
Each patient receives enough time to describe their challenges, goals, and previous attempts, and this information becomes the foundation for a personalized treatment plan